ArticleOncology letters2025

CMTM4 promotes the motility of colon cancer cells under radiation and is associated with an unfavorable neoadjuvant chemoradiotherapy response and patient survival in rectal cancer.

Lujing Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.